Effect and mechanism of erythropoietin on light-induced damage in retinal Müller cells

GONG Yiqing; MENG Nana

doi:10.7619/jcmp.20211983

Journal of Clinical Medicine in Practice > 2021 > 25(20): 28-32. > DOI: 10.7619/jcmp.20211983

GONG Yiqing, MENG Nana. Effect and mechanism of erythropoietin on light-induced damage in retinal Müller cells[J]. Journal of Clinical Medicine in Practice, 2021, 25(20): 28-32. DOI: 10.7619/jcmp.20211983

Citation:

PDF (852 KB)

Effect and mechanism of erythropoietin on light-induced damage in retinal Müller cells

Ophthalmology Department, the Affiliated People's Hospital of Jiangsu University, Zhenjiang First People's Hospital, Zhenjiang, Jiangsu, 212002

More Information

Received Date: May 11, 2021
Available Online: November 15, 2021
Published Date: October 27, 2021

Graphical Abstract

Abstract

Abstract

Objective To explore the effect and mechanism of erythropoietin(EPO)on light-induced retinal damage in Müller cells.
Methods Primary Müller cells of mice cultured were selected and divided into ultraviolet free group (control group) and ultraviolet group, each group was treated with different concentrations of EPO. The 3-(4, 5-demethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay was used to detect cell viability. Western blot was used to detect the rotein kinase B(Akt) levels in EPO-activated Müller cells. Müller cells were divided into dimethyl sulfoxide (DMSO) control group(DMSO group)and inhibitors of Akt MK-2206 group(MK-2206 group). The above cells were treated in three ways: ① no ultraviolet group without treatment; ② ultraviolet group with ultraviolet radiation (30 mJ/cm2) for 30 min; ③ ultraviolet + drug group[the cells were pretreated with 1 μg/mL EPO for 30 min, and then treated with ultraviolet (30 mJ/cm²) radiation for 30 min]. The cell viability was detected by MTT. A total of 24 mice were divided into four groups: no injection group (right eye of mice, n=6), injection group (left eye of mice, n=6), illumination group (no injection eye receiving illumination, n=6) and illumination + injection group (injection eye receiving illumination, n=6). The mice in each group were examined by flash electroretinogram to assess impaired visual function.
Results Optical density (OD) values of cells pretreated with different concentrations of EPO in the ultraviolet group showed significant differences compared with those in the no ultraviolet group (P < 0.05). Compared with untreated cells, OD values of pretreated cells by EPO (0.1, 1, 10 μg/mL) were significantly increased by MTT (P < 0.01). The protective effect of Müller cells induced by EPO was also enhanced with the increase of EPO concentration (0.1 and 1 μg/mL, respectively, P < 0.05), while the protective effects of 1 and 10 μg/mL treatments showed no statistically significant differences (P=0.114). After Müller cells were treated with EPO (0, 0.1, 1, 10 μg/mL) for 1 h, western blot analysis showed that the protein expression levels of p-Akt (Ser-473) and Akt1 increased, and there was concentration dependence in the range of 0.1 and 1 μg/mL. There was no significant difference in amplitude between non-injection group and injection group (P=0.17). There were statistically significant differences in amplitude between the no injection group and injection group(P=0.17). There were statistically significant differences in amplitude between the no injection group and the illumination group, the illumination + injection group (P < 0.05). The amplitude of illumination + injection group showed significant difference compared with the illumination group (P < 0.05).
Conclusion EPO alleviates retinal light damage in mice by activating Müller cell Akt signaling pathway.
- erythropoietin,
- Müller cell,
- light damage,
- signal pathway

FullText(HTML)

References (19)

References

[1]	ZHOU Z W, LI F, ZHENG Z T, et al. Erythropoietin regulates immune/inflammatory reaction and improves neurological function outcomes in traumatic brain injury[J]. Brain Behav, 2017, 7(11): e00827. doi: 10.1002/brb3.827
[2]	ANDREAS REICHENBACH, ANDREAS BRINGMANN. Glia of the human retina[J]. Glia, 2020, 68(4): 768-796. doi: 10.1002/glia.23727
[3]	MARQUARDT T, GRUSS P. Generating neuronal diversity in the Retina: one for nearly all[J]. Trends Neurosci, 2002, 25(1): 32-38. doi: 10.1016/S0166-2236(00)02028-2
[4]	HERNÁNDEZ C, FONOLLOSA A, GARCÍA-RAMÍREZ M, et al. Erythropoietin is expressed in the human Retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema[J]. Diabetes Care, 2006, 29(9): 2028-2033. doi: 10.2337/dc06-0556
[5]	MARTI H H. Erythropoietin and the hypoxic brain[J]. J Exp Biol, 2004, 207: 3233-3242. doi: 10.1242/jeb.01049
[6]	WEISHAUPT J H, ROHDE G POLKING E, et al. Effect of erythropoietin axotomy-inducedapoptosis in rat retinal ganglion cells[J]. Invest Ophthalmol Vis Sci, 2004, 45(5): 1514-1522. doi: 10.1167/iovs.03-1039
[7]	FU Q L, WU W, WANG H, et al. Up-regulated endogenous erythropoietin/erythropoietin receptor system and exogenous erythropoietin rescue retinal ganglion cells after chronic ocular hypertension[J]. Cell Mol Neurobiol, 2008, 28(2): 317-329. doi: 10.1007/s10571-007-9155-z
[8]	赵岩松, 赵堪兴, 王晓莉, 等. 低氧预适应对缺血再灌注损伤大鼠视网膜促红细胞生成素及活性caspase-3蛋白表达的影响[J]. 眼科新进展, 2013, 33(1): 5-8. https://www.cnki.com.cn/Article/CJFDTOTAL-XKJZ201301004.htm
[9]	曲虹, 厉泉. 促红细胞生成素对高浓度葡萄糖培养大鼠视网膜Müller细胞的保护作用[J]. 中华临床医师杂志: 电子版, 2015, 9(14): 2722-2725. doi: 10.3877/cma.j.issn.1674-0785.2015.14.024
[10]	黄靖妍, 杨曦. rHEPO对大鼠急性视网膜光损伤的保护作用及时效性研究[J]. 北华大学学报: 自然科学版, 2016, 17(5): 628-631. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLYY201605015.htm
[11]	LUO W, HU L, WANG F. The protective effect of erythropoietin on the Retina[J]. Ophthalmic Res, 2015, 53(2): 74-81. doi: 10.1159/000369885
[12]	ZHANG C, XIE H, YANG Q, et al. Erythropoietin protects outer blood-retinal barrier in experimental diabetic retinopathy by up-regulating ZO-1 and occludin[J]. Clin Exp Ophthalmol, 2019, 47(9): 1182-1197. doi: 10.1111/ceo.13619
[13]	SONG G, OUYANG G, BAO S. The activation of Akt/PKB signaling pathway and cell survival[J]. J Cell Mol Med, 2005, 9(1): 59-71. doi: 10.1111/j.1582-4934.2005.tb00337.x
[14]	PAPADIMITRAKOPOULOU V. Development of PI3K/AKT/mTOR pathway inhibitors and their application in personalized therapy for non-small-cell lung cancer[J]. J Thorac Oncol, 2012, 7(8): 1315-1326. doi: 10.1097/JTO.0b013e31825493eb
[15]	LINDSLEY C W, ZHAO Z, LEISTER W H, et al. Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors[J]. Bioorg Med Chem Lett, 2005, 15(3): 761-764. doi: 10.1016/j.bmcl.2004.11.011
[16]	SHIKUN HE, XIAOHUA LI, NYMPH CHAN, et al. Epigenetic mechanisms in ocular disease[J]. Mol Vis, 2013, 19(21): 665-674.
[17]	TAO Y, LI C, YAO A, et al. Intranasal administration of erythropoietin rescues the photoreceptors in degenerative Retina: a noninvasive method to deliver drugs to the eye[J]. Drug Deliv, 2019, 26(1): 78-88. doi: 10.1080/10717544.2018.1556361
[18]	HU L M, LUO Y, ZHANG J F, et al. EPO reduces reactive gliosis and stimulates neurotrophin expression in Muller cells[J]. Front Biosci (Elite Ed), 2011, 1(3): 1541-1555.
[19]	TAN B, MACLELLAN B, MASON E, et al. Structural, functional and blood perfusion changes in the rat Retina associated with elevated intraocular pressure, measured simultaneously with a combined OCT+ERG system[J]. PLoS One, 2018, 13(3): e0193592. doi: 10.1371/journal.pone.0193592

[1]	WANG Zhenglin, CHANG Weicai, LIU Xinyu, CHEN Jiawei, LIU Zixiang, ZHOU Shaobo. Role of tumor necrosis factor-α in promoting gallbladder cancer cell proliferation through Wnt/β-catenin signaling pathway[J]. Journal of Clinical Medicine in Practice, 2023, 27(19): 40-45. DOI: 10.7619/jcmp.20230255
[2]	Qilimuge, LI Xuelian, JI Qiang. Research progress on relationship between receptor tyrosine kinase-like orphan receptor 1 and signaling pathway of tumor cells[J]. Journal of Clinical Medicine in Practice, 2023, 27(17): 133-139. DOI: 10.7619/jcmp.20231087
[3]	YANG Yanni, ZHAO Ziwei, LI Xinhua. Research progress of mitogen activated protein kinase signaling pathway in pathogenesis of psoriasis vulgaris[J]. Journal of Clinical Medicine in Practice, 2022, 26(18): 136-139. DOI: 10.7619/jcmp.20220406
[4]	ZHANG Feng, ZHENG Gang, QI Jing, GAO Yuan. Research progress of inflammatory signaling pathway associated with atherosclerosis[J]. Journal of Clinical Medicine in Practice, 2022, 26(10): 144-148. DOI: 10.7619/jcmp.20214777
[5]	XIA Deguo, YAN Keshi, LU Dahao, ZHANG Chi, GAO Ju. Study on remifentanilin inhibiting Notch signal pathway and cell growth of human hepatocarcinoma cells[J]. Journal of Clinical Medicine in Practice, 2022, 26(8): 32-36. DOI: 10.7619/jcmp.20214486
[6]	WEN Bo, LIU Zixiang, ZHANG Ziyan, CHEN Jiawei, WANG Zhenglin, ZHOU Shaobo. Effect of overexpression of heparanase on proliferation of gallbladder cancer cells and PI3K/AKT signaling pathway[J]. Journal of Clinical Medicine in Practice, 2022, 26(2): 56-61. DOI: 10.7619/jcmp.20213823
[7]	CAO Qin, WANG Dan. Mechanism of ropivacaine inhibiting the proliferation, migration and invasion of gastric cancer cell NCI-N87 through Wnt signaling pathway[J]. Journal of Clinical Medicine in Practice, 2021, 25(20): 56-60, 67. DOI: 10.7619/jcmp.20211771
[8]	LIU Juan, CHEN Canming, XU Yang, ZHANG Wei, ZHANG Lei. Interaction between aromatic hydrocarbon receptor signaling pathway-related gene polymorphism and its mRNA in the development of endometriosis[J]. Journal of Clinical Medicine in Practice, 2019, 23(13): 1-5, 9. DOI: 10.7619/jcmp.201913001
[9]	WANG Hua, WANG Jingcheng, WANG Yongxiang, WANG Daxin, TAO Yuping, FENG Xinmin, XIONG Chuanzhi, GU Jiaxiang, HE Jinshan. Role of NEP1-40 in regulation of Wnt signaling pathway and regeneration of neural cells in neonatal rats with hypoxic ischemic encephalopathy[J]. Journal of Clinical Medicine in Practice, 2017, (5): 1-4. DOI: 10.7619/jcmp.201705001
[10]	LI Juan. Participation mechanism of TGFβ/Smad signaling pathway in the pathogenesis of cognitive dysfunction in cerebral infarction patients[J]. Journal of Clinical Medicine in Practice, 2015, (17): 21-23,27. DOI: 10.7619/jcmp.201517007

Cited By

Cited by

Periodical cited type(10)

1.	方慧孜，单海霞，王利维，陈燕. 基于思维导图的风险管理模式在新生儿窒息中的应用效果. 中国医药导报. 2024(03): 179-182 .
2.	张姗姗，丁婧，秦好奇，张茜. 不同机械通气方案联合多巴酚丁胺治疗新生儿持续肺动脉高压的临床效果对比. 河南医学研究. 2024(17): 3140-3142 .
3.	张耀华. 新生儿窒息复苏后持续肺动脉高压分析. 包头医学. 2023(01): 14-15+34 .
4.	曹娜. 新生儿窒息复苏后持续肺动脉高压的影响因素. 中国医药指南. 2023(22): 110-112 .
5.	王然，张天虎. 新生儿窒息复苏后持续性肺动脉高压的影响因素与预防干预措施. 名医. 2023(19): 39-41 .
6.	郭朝利. 新生儿窒息原因分析及多科室协作在复苏护理中的应用研究. 中国药物与临床. 2021(05): 892-894 .
7.	王亚红，周莲娟，朱姗姗. 新生儿窒息复苏后持续性肺动脉高压影响因素的病例对照研究. 中国妇幼保健. 2021(14): 3314-3316 .
8.	孙丽丽. 高频振荡通气联合猪肺磷脂注射液治疗新生儿胎粪吸入综合征并肺动脉高压的效果. 河南医学研究. 2021(32): 6048-6051 .
9.	阮敏仪，李敏许，杨勇，苏锦珍，邓皓辉. 早产儿与足月儿发生新生儿持续性肺动脉高压的特点分析. 中国医学创新. 2020(12): 157-160 .
10.	马旭涛，赵蒙. 围生期窒息患儿颅脑超声影像学特点. 河南医学研究. 2020(29): 5504-5506 .

Other cited types(1)

Get Citation

PDF

XML

Article views (261) PDF downloads (13) Cited by(11)

Turn off MathJax

Article Contents

Abstract

References

Effect and mechanism of erythropoietin on light-induced damage in retinal Müller cells